Caribou Biosciences, Inc. Intellectual Property Contracts & Agreements

8 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 3 to the Exclusive License Agreement, dated April 16, 2021, by and among the Registrant, The Regents of the University of California, and the University of Vienna
License Agreements
Caribou Biosciences, Inc.
Biotechnology
2021
Amendment No. 2 to the Exclusive License Agreement, dated April 17, 2013, by and among the Registrant, The Regents of the University of California, and the University of Vienna
License Agreements
Caribou Biosciences, Inc.
Biotechnology
2021
Amendment No. 1 to the Exclusive License Agreement, dated April 16, 2013, by and among the Registrant, The Regents of the University of California, and the University of Vienna
License Agreements
Caribou Biosciences, Inc.
Biotechnology
2021
Exclusive License Agreement dated as of April 16, 2013, by and among the Registrant, The Regents of the University of California, and the University of Vienna
License Agreements
Caribou Biosciences, Inc.
Biotechnology
CA
2021
Addendum to License Agreement, dated as of February 2, 2016, by and between the Registrant and Intellia Therapeutics, Inc. as successor in interest to Intellia, LLC
License Agreements
Caribou Biosciences, Inc.
Biotechnology
2021
Amendment No. 1 to the License Agreement, dated February 2, 2016, by and between the Registrant and Intellia Therapeutics, Inc. as successor in interest to Intellia, LLC
License Agreements
Caribou Biosciences, Inc.
Biotechnology
2021
License Agreement dated as of July 16, 2014, by and between the Registrant and Intellia, LLC
License Agreements
Caribou Biosciences, Inc.
Biotechnology
NY
2021
Exclusive License Agreement dated as of November 13, 2020, by and between the Registrant and Memorial Sloan Kettering Cancer Center
License Agreements
Caribou Biosciences, Inc.
Biotechnology
NY
2021